Modern Dental Europe Ltd. has acquired Permadental Holding B.V. from Foreman Capital
Modern Dental Europe Ltd. (MDL) has acquired Permadental Holding B.V. (Permadental) from Foreman Capital.
MDL produces dental prosthesis for dentists and doctors around the world. The company is part of the Modern Dental Holding Ltd group, one of the largest dental laboratories in the world, with production facilities in Shenzhen, China.
Permadental is the importer and supplier of dental prosthesis in the German market. The company has a track record of serving dentists for over 25 years by supplying them with crowns, bridges, implants and telescopic crowns, all manufactured in China.
Founded by Arent Foch and Guido ter Kuile in 2005, Foreman Capital is an independent investment company focused on investments in European companies that are active in trade, manufacturing and service provision.
Oaklins' team in the Netherlands advised the buyer in this transaction.


Talk to the deal team
Related deals
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn moreAfric Phar has been acquired by Pharma Capital
Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more